Skip to main content

News

Filter

Exploring immune innovation: an interview with Holger Heyn

29 November 2024

EPIVINF researcher participates in new studies on HIV infection and neuroinflammation in patients

18 November 2024

Neurocognitive impairments in Long COVID: an emerging concern

23 October 2024

EPIVINF General Assembly Meeting focuses on key advances in viral infection research

3 October 2024

Exploring the molecular landscape of viral diseases through bioinformatics: an interview with Tobias Wolff

30 September 2024

Mapping epigenetic shifts in HIV and SARS-CoV-2: an interview with Marta Ruiz-Riol

19 July 2024

Exploring neurocognitive impairments in Long Covid: an interview with Marta Massanella

25 June 2024

SIRT2 protein unveiled as potential therapeutic target for HIV-associated neurological dysfunction

14 May 2024

Study suggests vagus nerve dysfunction may explain post-COVID symptoms

10 April 2024

Study identifies CD33 as potential marker and therapeutic target for HIV Control

4 April 2024

EPIVINF annual meeting advances global understanding of viral infections

22 November 2023

A detailed evaluation of potential animal models to study persistent neurological symptoms of COVID-19

24 October 2023
EPIVINF Kick-off Meeting

Welcome on board the EPIVINF project: the kick-off meeting

25 October 2022
Epigenetic differences in the DNA

Epigenetic differences in the DNA of people living with HIV can affect their natural ability to control the virus

5 August 2020

Press Office

E-mail:
comunicacio@irsicaixa.es  

Phone number:
(+34) 93 465 63 74. Ext. 221 

Address: 
Hospital Universitari Germans Trias i Pujol.
Ctra del Canyet, s/n, 08916 Badalona (Barcelona), Spain 

EPIVINF